Published in Neurologist on January 01, 2005
Health status in long-term survivors of pediatric craniopharyngiomas. J Neurosci Nurs (2010) 0.99
Factors influencing quality of life in patients with benign primary brain tumors: prior to and following surgery. Support Care Cancer (2010) 0.84
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
The landscape of somatic copy-number alteration across human cancers. Nature (2010) 31.88
Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res (2003) 8.06
Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol (2011) 6.67
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature (2012) 5.23
Dissecting the genomic complexity underlying medulloblastoma. Nature (2012) 4.77
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J Clin Oncol (2010) 4.48
Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance. Cell (2010) 4.37
Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature (2012) 4.13
Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun (2011) 4.07
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol (2012) 3.88
Medulloblastomics: the end of the beginning. Nat Rev Cancer (2012) 3.01
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis. Lancet Oncol (2013) 2.82
Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation. Cancer Cell (2010) 2.80
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta Neuropathol (2011) 2.53
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet (2013) 2.42
Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis. Lancet Oncol (2012) 2.34
Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers. Genes Dev (2004) 2.16
Progressive myoclonus in a child with a deep cerebellar mass. Neurology (2003) 2.16
Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation. Proc Natl Acad Sci U S A (2005) 1.96
The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes Dev (2008) 1.93
Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors. Cancer Cell (2009) 1.92
Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway. Nat Med (2010) 1.77
Urinary biomarkers predict brain tumor presence and response to therapy. Clin Cancer Res (2008) 1.72
Ataxia and shaking in a 2-year-old girl: acute marijuana intoxication presenting as seizure. Pediatr Emerg Care (2005) 1.57
Cytogenetic prognostication within medulloblastoma subgroups. J Clin Oncol (2014) 1.56
Spontaneous occlusion of the circle of Willis in children: pediatric moyamoya summary with proposed evidence-based practice guidelines. A review. J Neurosurg Pediatr (2012) 1.56
Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma. Acta Neuropathol (2012) 1.56
Wound complications associated with the use of bovine serum albumin-glutaraldehyde surgical adhesive in pediatric patients. Neurosurgery (2007) 1.47
Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. J Clin Oncol (2013) 1.43
Cavernous malformations of the brain after treatment for acute lymphocytic leukemia: presentation and long-term follow-up. J Neurosurg Pediatr (2012) 1.40
Linear vein-based arteriovenous malformations in children. J Neurosurg Pediatr (2009) 1.38
Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic features. J Clin Oncol (2011) 1.36
Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability. Mol Cell Biol (2008) 1.36
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol (2013) 1.35
Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1. Proc Natl Acad Sci U S A (2013) 1.33
Medulloblastoma tumorigenesis diverges from cerebellar granule cell differentiation in patched heterozygous mice. Dev Biol (2003) 1.29
CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Acta Neuropathol (2014) 1.28
Combining gene expression profiles and clinical parameters for risk stratification in medulloblastomas. J Clin Oncol (2004) 1.26
Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization. Pediatrics (2005) 1.21
Focus on central nervous system neoplasia. Cancer Cell (2002) 1.18
INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma. J Neuropathol Exp Neurol (2005) 1.17
A novel syndrome caused by the E410K amino acid substitution in the neuronal β-tubulin isotype 3. Brain (2013) 1.15
Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor. J Neurooncol (2005) 1.13
Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group. Acta Neuropathol (2013) 1.12
Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization. J Neurosurg Pediatr (2013) 1.12
UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53. Nat Med (2011) 1.12
Surgical management of moyamoya syndrome. Skull Base (2005) 1.12
miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma. Neuro Oncol (2010) 1.10
Progression of disease in unilateral moyamoya syndrome. Neurosurg Focus (2008) 1.10
Diencephalic syndrome: a cause of failure to thrive and a model of partial growth hormone resistance. Pediatrics (2005) 1.06
Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial. Int J Radiat Oncol Biol Phys (2005) 1.05
Tethered cord syndrome. Neurosurg Clin N Am (2007) 1.05
Schwann cell proliferation during Wallerian degeneration is not necessary for regeneration and remyelination of the peripheral nerves: axon-dependent removal of newly generated Schwann cells by apoptosis. Mol Cell Neurosci (2008) 1.03
Intracerebral abscess in children: historical trends at Children's Hospital Boston. Pediatrics (2004) 1.03
High-resolution imaging demonstrates dynein-based vesicular transport of activated Trk receptors. J Neurobiol (2002) 1.02
Moyamoya: epidemiology, presentation, and diagnosis. Neurosurg Clin N Am (2010) 1.02
Everyday cognitive function after craniopharyngioma in childhood. Pediatr Neurol (2006) 1.01
Outcome of pediatric pineoblastoma after surgery, radiation and chemotherapy. J Neurooncol (2008) 1.00
Overlay analysis of the oligonucleotide array gene expression profiles and copy number abnormalities as determined by array comparative genomic hybridization in medulloblastomas. Genes Chromosomes Cancer (2007) 0.99
Pial arteriovenous fistulae in pediatric patients: associated syndromes and treatment outcome. J Neurointerv Surg (2012) 0.99
Gain of 1q is a potential univariate negative prognostic marker for survival in medulloblastoma. Clin Cancer Res (2007) 0.98
A recurrent craniopharyngioma illustrates the potential usefulness of urinary matrix metalloproteinases as noninvasive biomarkers: case report. Neurosurgery (2007) 0.97
Medulloblastoma outcome is adversely associated with overexpression of EEF1D, RPL30, and RPS20 on the long arm of chromosome 8. BMC Cancer (2006) 0.97
Levels of soluble adhesion molecules are elevated in the cerebrospinal fluid of children with moyamoya syndrome. Neurosurgery (2002) 0.96
MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma. Acta Neuropathol (2011) 0.96
Neuroimaging in pediatric brain tumors: Gd-DTPA-enhanced, hemodynamic, and diffusion MR imaging compared with MR spectroscopic imaging. AJNR Am J Neuroradiol (2002) 0.94
Medical, psychological, cognitive and educational late-effects in pediatric low-grade glioma survivors treated with surgery only. Pediatr Blood Cancer (2009) 0.94
A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma. Int J Radiat Oncol Biol Phys (2003) 0.92
Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme. J Neurooncol (2006) 0.92
Primary medulla oblongata germinoma: a case report and review of the literature. J Neurooncol (2003) 0.90
Intrasacral meningocele in the pediatric population. J Neurosurg Pediatr (2013) 0.90
Outcome following multiple repeated spinal cord untethering operations. J Neurosurg (2007) 0.90
Sleep dysfunction in long term survivors of craniopharyngioma. J Neurooncol (2012) 0.90
Biochemical characterization of pediatric brain tumors by using in vivo and ex vivo magnetic resonance spectroscopy. J Neurosurg (2002) 0.89
Mutational analysis of 206 families with cavernous malformations. J Neurosurg (2003) 0.89
Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors. Cell Cycle (2012) 0.88
Seckel syndrome and moyamoya. J Neurosurg Pediatr (2009) 0.88
Medulloblastomas and primitive neuroectodermal tumors rarely contain polyomavirus DNA sequences. Neuro Oncol (2002) 0.87
Sickle Cell Disease. N Engl J Med (2017) 0.86
Idiopathic syrinx in the pediatric population: a combined center experience. J Neurosurg Pediatr (2011) 0.86
Magnetic resonance imaging of patched heterozygous and xenografted mouse brain tumors. J Neurooncol (2003) 0.86
Cavernous malformations. Neurosurg Clin N Am (2010) 0.86
Neuropsychological functioning after surgery in children treated for brain tumor. Neurosurgery (2003) 0.85
Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome. Neurosurg Focus (2009) 0.85
Hedgehog-GLI pathway in medulloblastoma. J Clin Oncol (2012) 0.85
Resection of supratentorial lobar cavernous malformations in children: clinical article.. J Neurosurg Pediatr (2013) 0.84
Chemotherapy for progressive low-grade gliomas in children older than ten years: the Dana-Farber experience. Pediatr Hematol Oncol (2003) 0.84
Moyamoya disease in children with congenital dwarfing conditions. Pediatr Neurosurg (2011) 0.84
A novel role for extracellular signal-regulated kinase 5 and myocyte enhancer factor 2 in medulloblastoma cell death. Cancer Res (2005) 0.84
Long-term clinical outcomes following treatment of childhood craniopharyngioma. Pediatr Blood Cancer (2010) 0.83
Marked regression of metastatic pilocytic astrocytoma during treatment with imatinib mesylate (STI-571, Gleevec): a case report and laboratory investigation. J Pediatr Hematol Oncol (2003) 0.82
Spinal cord abnormalities in sports. Clin Sports Med (2012) 0.82